The SRB assay has been used since its development in 1990 (Skehan et al., 1990) to inexpensively conduct various screening assays to investigate cytotoxicity in cell based studies (Vichai and Kirtikara, 2006) . This method relies on the property of SRB, which binds stoichiometrically to proteins under mild acidic conditions and then can be extracted using basic conditions; thus, the amount of bound dye can be used as a proxy for cell mass, which can then be extrapolated to measure cell proliferation.
Background
The SRB assay has been widely used to investigate cytotoxicity in cell based studies and it is the method of choice for high cost-effective screenings (Vichai and Kirtikara, 2006) . Since this method does not rely on measuring metabolic activity [e.g., 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide, MTT], the steps required to optimize the protocol for a specific cell line are substantially simplified.
The protocol described here has been optimized for medium throughput screening of miRNAs with tumor suppressive properties in adherent lung cancer cells in 96-well format and 384-well format (Kasinski et al., 2015) . Particularly the SRB assay in 384-well format offers the advantage of screening large number of miRNA mimics or compounds in a single plate (> 60 per plate, 6 replicates) using inexpensive equipment and reagents. 
Materials and Reagents

16.
Opti-MEM ® (Thermo Fisher Scientific, Gibco ™ , catalog number: 31985070) or serum free medium (SFM, appropriate culture medium before adding fetal bovine serum)
17.
Phosphate buffered saline (PBS) (GE Healthcare, catalog number: SH30256)
18.
Trypsin solution (2.5%, wt/vol) (GE Healthcare, catalog number: SH30042.01)
19.
Fatal bovine serum (FBS) (Sigma-Aldrich, catalog number: F2442)
20.
Trypan blue (Sigma-Aldrich, catalog number: T9154)
21.
Trichloroacetic acid (TCA) (Sigma-Aldrich, catalog number: 91228)
22.
Sulforhodamine B sodium salt (SRB) (Sigma-Aldrich, catalog number: S1402) in 1% (vol/vol) acetic acid
23.
Acetic acid (Thermo Fisher Scientific, Fisher Scientific, catalog number: S25118)
24.
10 mM unbuffered Tris base solution (Sigma-Aldrich)
25.
DNAse/RNAse free water (Thermo Fisher Scientific, Ambion ™ , catalog number: AM9932)
26.
Lipofectamine RNAimax (Thermo Fisher Scientific, Invitrogen ™ , catalog number: 13778150)
27.
Mirvana miRNA mimics (Thermo Fisher Scientific, Ambion ™ )
28.
miRNA precursor molecules -negative control #2 (non-targeting scramble miRNA) (Thermo Fisher Scientific, Ambion ™ , catalog number: AM17111) Equipment
1.
Pipettes (Mettler-Toledo International, catalog numbers: L-1000XLS)
2.
Pipettes (Mettler-Toledo International, catalog numbers: L200-XLS)
3.
Pipettes (Mettler-Toledo International, catalog numbers: L20-XLS)
4.
Pipettes (Mettler-Toledo International, catalog numbers: L2-XLS)
5.
Multichannel 
2.
Treatment can be prepared in aqueous solution (Opti-MEM for transfections) or solvent of choice (e.g., DMSO).
B. Cell preparation
1.
Remove medium from cell monolayers and wash the cells once with sterilized PBS.
2.
Remove PBS and add 1 ml (100 mm plates) 0.25% (wt/vol) trypsin to evenly cover the cell-growth surface.
3.
Incubate at 37 °C for 5 min or until cells start to dissociate.
4.
Next inactivate trypsin with 10 volumes of culture medium containing FBS, and mix up and down to obtain a homogeneous single cell suspension.
5.
Transfer the cell suspension to a sterile Falcon tube. Determine the cell concentration by counting in a hematocytometer chamber under a microscope using a 1:1 mixture of cell suspension and 0.4% (wt/vol) trypan blue solution to determine cell viability prior cell seeding. Optional: before counting, spin down cells in order to wash trypsin and resuspend in growth medium.
Note: Only proceed to next steps if cells in solution look healthy by checking trypan blue staining (Figure 1 ).
6.
Adjust the cell concentration with growth medium (10% FBS) to obtain an appropriate cell seeding density per well in a volume of 50 μl (96-well format) or 10 μl (384-well format).
Note: Initial cell seeding density will depend on two main factors: 1) doubling time of the cell line used and 2) the day the plate will be read. Cells are typically at 70-80% confluency (2 × 10 4 for 96-well format and 8 × 10 3 for 384-well format) by the end of the experiment (day 5).
7.
Transfer the cell suspension into a sterile reagent reservoir to make it easier to pipette with a multichannel pipette.
C. Treatment exposure
1.
Mix the treatment solutions prepared in step A by pipetting. Dispense 50 μl (96well format) or 10 μl (384-well format) of solution into each well.
2.
Mix cell suspension prepared in step B thoroughly and add 50 μl (96-well format) or 10 μl (384-well format) to each well already containing treatment solutions.
Note: Ensure even cell distribution in the bottom of the plate and avoid shaking the plate to avoid 'ring effects'. The best way to achieve this is to add the cell solution directly to the bottom of the well, avoiding touching the walls. We also recommend performing a short spin of the plate (20 sec, 10 × g) before placing it in the incubator.
3.
Set aside three wells in the plate containing only Opti-MEM or solvent of choice and cell suspension for an untreated or vehicle control. Also, leave three wells in the plate containing only medium for background subtraction.
4.
Incubate the plate at 37 °C in a humidified incubator with 5% CO 2 until plate is to be read.
Note: The incubation time will depend on the type of compound being tested and has to be experimentally determined. For example, in our hands we observe the biggest difference in cell proliferation between negative control and a tumor suppressive miRNA 5 days following transfection.
D. Cell fixation and staining
1.
Gently add 25 μl (96-well format) or 5 μl (384-well format) cold 50% (wt/vol) TCA to each well directly to medium supernatant, and incubate the plates at 4 °C for 1 h. Mixing is not required, as this could lead to some cells detaching from the bottom of the well.
Wash the plates four times by submerging the plate in a tub with slow-running tap water and remove excess water by gently tapping the plate into a paper towel. After the last wash allow the plate to air-dry at room temperature.
Note: Cell monolayer detachment can occur if water is forced into the wells. We recommend letting the plate dry completely before continuing to next step. If necessary, dried plates can be stored at room temperature indefinitely.
2.
Add 50 μl (96-well format) or 20 μl (384-well format) of 0.04% (wt/vol) SRB solution to each well.
Note: Ensure that the solution is in direct contact with the bottom of the well and that there are no bubbles in between. SRB solution is not light sensitive thus plate does not need to be covered during incubation.
3.
Leave at room temperature for 1 h and then quickly rinse the plates four times with 1% (vol/vol) acetic acid (200 μl for 96-well format or 30 μl for 384-well format) to remove unbound dye. Allow the plate to air-dry at room temperature.
Note: Non-homogeneous washes are a major source of error in this assay. Washes must be done quickly and homogeneously across the entire plate. This is particularly important for 384-well format. The small area of the wells leads to high superficial tension sometimes making it difficult to wash the plates uniformly. Visually check that all the wells in the plate have been injected with 1% (vol/vol) acetic acid and that there are no bubbles preventing the washes. We recommend washing with multi-channel pipet and injecting the solution indirectly into the wells using the walls of the wells.
a.
MiRNA-liposomal complexes can be prepared in serum free/antibiotic free medium.
b.
The amount of Lipofectamine RNAimax must be empirically determined for each cell line to be used in order to identify the amount of reagent that provides the maximum transfection efficiency and minimal cell toxicity. This eliminates the need of changing media after transfection, which is a common source of variation in these types of assays.
c.
In our hands, we determined that 0.12 μl (for 96-well plastes -100 μl) or 0.05 μl (for 96-well plates -20 μl) of Lipofectamine RNAimax was enough to transfect 6 nM of miRNA mimic with minimal toxicity in a panel of non-small cell lung cancer cells. Each transfection should be replicated in the same plate (we recommend at least 3 replicates in a 96well plate or 6 in a 384-well plate).
d.
From our experience, reverse transfection reduces the time of the assay and at the same time reduces sources of variation during changes of media before transfection, washing steps and replacement of Opti-MEM after transfection.
